comparemela.com
Home
Live Updates
Cereno Scientific : shares progress update in the Phase II study with drug candidate CS1 in the rare disease PAH : comparemela.com
Cereno Scientific : shares progress update in the Phase II study with drug candidate CS1 in the rare disease PAH
Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced an updated progress report of the Phase II study in pulmonary... | May 12, 2023
Related Keywords
Jonas Fogelberg ,
,
Cereno Scientific ,
Cereno Scientific Ab Publ Stock Exchange ,
News ,
Information ,
Press Release ,
Sereno ,
Cientific ,
Company ,
Developing ,
Nnovative ,
Treatments ,
Or ,
Common ,
End ,
Mare ,
Ardiovascular ,
Oday ,
Nnounced ,
N ,
Pdated ,
Progress ,
Report ,
F ,
The ,
Hase ,
Hi ,
Study ,
N Crnob Se0008241558 ,
comparemela.com © 2020. All Rights Reserved.